Latest / Newcomer Pod / Psychedelics, Micro Nuclear Reactors & Venture Turbulence (with Rebecca Kaden)
Transcript
- 0:01Hey, I'm Eric Newcomer. This week we have Rebecca Cayden
- 0:04on the show from Union Square Ventures.
- 0:06Great episode. We start off talking about
- 0:08psychedelics only gets more from from there.
- 0:11We talked about US V's climate fund, the downturn, her career
- 0:15in venture capital. I think you're really enjoying
- 0:17the episode. Give it a list.
- 0:19It's Eric Newcomer here with Rebecca Cayden at Union Square
- 0:23Ventures. Very excited to have you on the
- 0:25podcast. Thanks for joining me.
- 0:28Thanks for having me. This is fun.
- 0:30I think we first met when you were at Mavron.
- 0:34We had dinner at one of maybe the mission Burma love.
- 0:38Yeah, it's so good. I haven't been there in a long
- 0:40time, but it's delicious. And then I've seen you.
- 0:44I think especially memorable was the first Slow Ventures summit
- 0:48for sort of the UP and comers were right.
- 0:50You were sort of like the, I've made it, you know, I'm at USV
- 0:55but I can sort of give the wisdom, yeah, to everybody else
- 1:00a little earlier in their careers.
- 1:01Anyway, a lot to talk about on the episode.
- 1:04I mean I think later on maybe we'll talk about some of that
- 1:07like you know, venture career stuff and sort of being at USV
- 1:12and sort of the downturn which is interesting.
- 1:14But you know, you have some fun portfolio companies and I wanted
- 1:18to jump in, in particular just talking about Journey Clinical,
- 1:24which you've told me some about, but you know is in sort of the
- 1:28is psychedelics 2 strong words psychedelic space or what?
- 1:32Tell us a little bit about Journey Clinical and how you got
- 1:35excited about that company. Yeah, Journey Clinical is a
- 1:39network of therapists. And what Journey does is provide
- 1:44education and access for therapists to learn about and
- 1:48prescribe and utilize the newest.
- 1:51Treatments and options with their patients.
- 1:54Right now the focus is on psychedelics and particularly
- 1:57ketamine. But over time as new treatments
- 2:00evolve and get regulated and become available, Journey is the
- 2:04go to platform for their members to learn about them, understand
- 2:08how to use them and for their patients to get prescribed as
- 2:12they need to. You know, our thesis there
- 2:14really starts at a higher elevation with our, you know,
- 2:17thoughts on mental health, I think.
- 2:19You know, it's now relatively common wisdom that we've moved
- 2:22from a, you know, mental health problem to a full on mental
- 2:25health crisis in this country. I think it's, you know, one of
- 2:28the top three epidemics that we're facing.
- 2:31You know, there's kind of like. Climate change, you know,
- 2:34actually, there's probably many other epidemics, but it's a big
- 2:37one, right? And it's actually too many to
- 2:39name change tracks to another USB fun.
- 2:41You're like, oh, we've got a fun for all the.
- 2:43Big all the major crises of our time, but this is one of them
- 2:46and it's pervasive and it actually relates to a lot of
- 2:49other crises that we're facing around climate polarization, you
- 2:54know, loneliness. And it's something we talk about
- 2:56a lot and we've been very interested in it from a venture
- 2:59business perspective. The 1st.
- 3:01Kind of generation of mental health companies, we're really
- 3:04around access to care and that's a bucket that we've played in as
- 3:07well and believe create really good businesses and will go on
- 3:10to create great outcomes. But it's primarily around
- 3:13bringing that care online and getting it paid for.
- 3:16Those are two extremely important things and one
- 3:19interesting thing to me about that is that market alone.
- 3:22I think it's going to support dozens of billion dollar
- 3:26companies, maybe more we can all think of.
- 3:28A fair number. I think that market has turned
- 3:31out to be way more powerful, the market, sorry, that market
- 3:34being. Access to mental health care,
- 3:37right, Getting mental health care online and paid for, right.
- 3:41In our portfolio, we think about Brave Health.
- 3:43There's also, you know, whether it's all more or headway or
- 3:47spring or lira, there's a lot of these, right?
- 3:49And many of them are very good businesses and important ones
- 3:54and you know. Are are constrained on supply
- 3:57and demand despite the number in the market because there's so
- 3:59many elements of mental health care to touch that need that
- 4:03access to be provided. People are fascinated by, you
- 4:07know the USV sort of process. I mean obviously the returns
- 4:11speak for themselves. I mean, I was just talking to
- 4:13one of your partners about case tax, you know, which sold for
- 4:18$650 million to Thompson Reuters and it's like, you know, it
- 4:22didn't really have a business model when you guys invested
- 4:25into some degree, that's what was like appealing.
- 4:29So I guess, you know, people want to know, like how you sort
- 4:32of repeatedly invest in weird things or like, how do you find
- 4:35something that sort of feels out there but is like you're doing
- 4:39it over and over again? I actually think this is a good
- 4:42example if we kind of keep pulling the thread of how
- 4:44Journey clinical came to be, right?
- 4:46Because. This thesis around access to
- 4:48care, which has attracted so much capital, some of it ours,
- 4:51and is proving to be a good category, you know, has been
- 4:54where the market has gone, but is actually only one piece of
- 4:58the puzzle. And so the way we get into
- 4:59things that are unusual is by having strong theses about where
- 5:03things are going versus being, you know, extremely
- 5:06opportunistic. And obviously there's a balance,
- 5:08but that thesis thinking is important, and a lot of thesis
- 5:12work on this category really led to the belief that access to
- 5:15care is only half the puzzle. Right.
- 5:17And the other is how is care itself going to evolve and you
- 5:21start unraveling that thread. Okay.
- 5:23How is care itself evolving? The real biggest last evolution
- 5:27of care is Ssri's, and those have been extremely successful
- 5:32and have done a lot of great things.
- 5:34Those are drugs to treat depression, basically.
- 5:36Yes, those are prescription drugs.
- 5:38You know, the roster that you've heard about and have been very
- 5:42important to the treatment for mental health crises.
- 5:44But. There's a lot of things they
- 5:46don't treat. They're not A1 size fits all
- 5:48model and they're basically all we got right.
- 5:51The innovation has not, you know, had a lot of other layers
- 5:56except for psychedelics. And so we've became very
- 5:59interested in psychedelics as you know, the next card to get
- 6:03turned over and the next option in needing a bucket of options
- 6:07to treat a crisis. And then you start, you know,
- 6:10talking to clinicians and researchers and therapists and
- 6:13understanding that we're really at a tipping point on it, right.
- 6:16Ketamine has been a legal drug for actually you know, quite a
- 6:19long time. That's not really new.
- 6:22And MDMA and psilocybin are progressing through clinical
- 6:25trials, you know pretty rapidly and there's becoming large
- 6:29clinical acceptance towards their role in treating mental
- 6:33health problems, but. There's also desire for it to be
- 6:38done in a controlled way and through the infrastructure of an
- 6:41ecosystem that's already in place.
- 6:43And so we were looking for that. How do you leverage the mental
- 6:46health ecosystem the therapists that are experts at this but
- 6:50also give them access to the newest options and that's how we
- 6:53got to journey clinical. Well, you know, whenever I, you
- 6:56know, sort of healthcare less somewhat to climate, there's the
- 7:02question of like why is this like a venture problem And
- 7:04outside of the existing, you know, medical system, like, I
- 7:08mean there are pharmaceutical companies, like why if there's
- 7:12money to be made, shouldn't they be trying like what's happening
- 7:15that it feels like you need a real sort of outsider thinking
- 7:18to bring ketamine, a drug, you know, that's legal to people's
- 7:23lives, that the medical system is unable or unwilling to do
- 7:27what's happening there? Well, this isn't really unique
- 7:30to psychedelics or to mental health.
- 7:32You know pharmaceutical companies make drugs.
- 7:35So the development of drugs falls with them, but the
- 7:37distribution and networks of access is outside of it and
- 7:41that's not particularly new or unique here.
- 7:44That's where business opportunity has been.
- 7:46So the idea is when you talk about distribution and networks
- 7:51of access, that's often where these business opportunities
- 7:54lie. You know, the development of
- 7:56drugs is kind of a different beast, which lies in the
- 7:59pharmaceuticals. But you know, why is there a
- 8:01business opportunity with creating access?
- 8:04Because the same reason technology drives business
- 8:06opportunity into anything. Offline access is slower, It's
- 8:10more gated, it's more piecemeal, right?
- 8:12You have to be at the right doctor at the right time.
- 8:14You have to find it. And then by creating a network,
- 8:18you just allow anyone anywhere to find access and education at
- 8:24a, you know, faster speed and with much broader supply, which
- 8:28brings efficiency to the market. This was Series A, right or like
- 8:33how far along his journey, on their journey.
- 8:36Yeah. Series A, but has grown rapidly
- 8:39like as you know, we invested in, call it November and it's
- 8:43Forex, maybe more since then. So it's, you know that I think
- 8:47they're a great team and have executed white well, but there's
- 8:50also strong tailwinds to this market that they're in on the
- 8:53regulatory side of it. Like, do you think, like,
- 8:57mushrooms are going to be sort of on the table soon or how much
- 9:00was this a bet that, yeah, the regulatory regime would change?
- 9:05I don't think mushrooms, as we think about them in, you know, a
- 9:08recreational sense are just going to get legalized.
- 9:11Maybe they will, but that's a separate kind of thing.
- 9:14I think other forms of psychedelics in, you know,
- 9:17formats that are right for care are very much going to get
- 9:21legalized. And actually, as we did our
- 9:23research, to us that's a when, not an if.
- 9:26You know when you dig into what's going on clinical trials
- 9:28and in that clinical world in some ways that seems you know
- 9:33pretty easy to bet on that these will continue to happen.
- 9:36And if not exactly the forms that we've outlined, rapid new
- 9:39forms of that options for care for mental health diseases are
- 9:44going to get, you know, approved and released and really have to
- 9:48and they're going to need a network of education.
- 9:51And distribution to go into to the therapist network and you
- 9:55know Journey isn't unique to a format, it should cover them.
- 9:59I do think there's regulatory risk here, but I actually
- 10:02obviously there's some amount of regulatory risk on psychedelics,
- 10:05right. We have to be honest about it.
- 10:06But I actually think more about regulatory risk across broader.
- 10:12Online healthcare in general. And I think we're at somewhat of
- 10:17a time of just still that whole market still getting worked out
- 10:22on not unique to mental health and not unique to psychedelics,
- 10:25but what you can prescribe online and to whom and to how
- 10:28and how to, you know, allow that really important access that
- 10:32we've come to rely on, but also do it in a you know,
- 10:35appropriately controlled way. Yeah.
- 10:38I mean, there's been sort of a fair bit of skeptical coverage
- 10:41about sort of the Adderall prescribing companies like Done.
- 10:48I mean, this sort of COVID era being able to prescribe drugs
- 10:52over video chat was obviously sort of hugely important to
- 10:57those companies. How much is that key to Journey
- 11:01and like yeah, what do you think about sort of the impact of sort
- 11:04of the more ADHD focused companies?
- 11:08So with Journey. Obviously, right now they
- 11:11utilize the ability to prescribe through online appointments.
- 11:16They do so through a lot of controls and I think in a very
- 11:19kind of specific and defined way.
- 11:22If they couldn't, they have a lot of other plans that you can
- 11:26do it with offline appointments that they could shift to.
- 11:28So it's not so dependent on that format, but for them and many
- 11:31others, it creates efficiency and a level of access that's
- 11:34really beneficial to the category.
- 11:36That being said, it can be abused.
- 11:38Right. And I think what we are seeing
- 11:40in this market is that I believe that, you know, one, businesses
- 11:46play out to the incentives that they're created with, not the
- 11:50kind of good or bad intense of the, you know, founders
- 11:53involved, right. So often times the mistakes made
- 11:56aren't malicious. It's that if you create a
- 11:59business model you know and you get scale, the business model
- 12:04will play out to the incentives that give it scale.
- 12:06And so if the incentive is purely sell more drugs, right,
- 12:10you will sell more drugs if you start to create scale and you
- 12:13will do internally what you need to in the business to make that
- 12:15happen. And if you don't have checks and
- 12:18balances internally and you don't have kind of catches to
- 12:21make sure that quality is an important piece of the business
- 12:24model who you're prescribing to. You know, making sure that goes
- 12:28to the right person when and the right appointments happen, You
- 12:32know, I think it can get away from you very quickly and I
- 12:35think we've seen that in the. Market here, but I am concerned
- 12:38that you know mistakes of this market getting developed that
- 12:42were really problematic might create problems horizontally
- 12:46that we just have to be prepared to face when kind of moving you
- 12:49know digital healthcare forward moving beyond you know this
- 12:53investment. I'm curious, I mean I mentioned
- 12:56in the beginning of the show, you know I met you coming from
- 12:59Mavron which was a very consumer focused firm and you know I've
- 13:03had Sarah Toble on a couple episodes ago and sort of took
- 13:07stock on the state of consumer. I'm curious like when you were
- 13:11interviewing with USV, was it clear in your mind you would be
- 13:14sort of shifting away from consumer and like what
- 13:18percentage of like consumer have you been doing since moving
- 13:23over? And how have you thought about
- 13:24it sort of professionally in this sort of period where
- 13:28consumers get tough and there are sort of big swings and you
- 13:31know it's, I don't know, it's a challenge.
- 13:33Yeah. I mean, we can table this, but I
- 13:35actually think consumer is about to become exciting in new ways.
- 13:39But you know, all right, well, I will circle back to that right.
- 13:42Now if you can circle back to that, but I think you know.
- 13:45Firms all have different designs and kind of cut the world in
- 13:48different ways. Mavron cut the world by being a
- 13:52category focused firm on consumer and doing that super
- 13:55well and by having those guard rails was able to develop
- 13:58expertise and brand and network in direct to consumer
- 14:02businesses. USV just cuts the world in a
- 14:04different way and I definitely knew that you know going in and
- 14:07it was something that and it is something that I'm excited
- 14:09about. We don't think a lot about kind
- 14:12of the divide in our portfolio. If we think about our fun
- 14:14construction or you know how we're looking at the world
- 14:16between consumer and B to B, what we think about is this
- 14:21thesis and kind of the mechanics involved, for instance, you
- 14:25know? The role of building network
- 14:28driven businesses and the opportunity to leverage you know
- 14:31bottom up networks to create modes and scale and to broaden
- 14:36access by driving you know value and down costs systematically
- 14:39across you know categories. We care about.
- 14:42You know, capital, well-being, knowledge and sometimes the
- 14:46right application when you pull the threads of that thesis is a
- 14:49consumer, you know, product or service and sometimes.
- 14:53It's the enabling infrastructure of them.
- 14:55But most of Usb's investments have been one of those two
- 14:58things. They've either been the end
- 15:00application or the enabling infrastructure involved.
- 15:04But a common theme throughout our investments is how do you
- 15:08build important networks that can change industries but rise
- 15:12outside of them. Like if you think about journey
- 15:14clinical right, it's a network, it's a network of therapists,
- 15:16they're stronger the more you add on to them.
- 15:19It's a bottom up growing network of acquiring the therapist even
- 15:22though it interacts with the healthcare system and can change
- 15:24it, but it's growing this network outside of the
- 15:27infrastructure to then. Impact the existing structure,
- 15:31we really like that if you think it like across of our
- 15:34investments and sometimes that turns out to be consumer if you
- 15:37think about you know an out school and education or a
- 15:40Duolingo or a Twitter and sometimes it turns out to be you
- 15:44know the enabling infrastructure or the B2B marketplace
- 15:48application like a journey clinical.
- 15:50So you know we just cut the world in a little bit of a
- 15:52different way. Do you think a lot about your
- 15:55sort of personal mix of investments or they tend to be
- 15:58firm wide or how do you think about how much consumer type
- 16:02investments you're doing now even though I know those can
- 16:05sometimes? Yeah.
- 16:05I don't think that much about how many of my investments are
- 16:08consumer and how many of my investments are beautiful.
- 16:10I do think about am I? Focused on a range of you know
- 16:15problems and thesis areas, right.
- 16:17If we think a lot about, you know, capital, knowledge and
- 16:19well-being, I want to, you know, be doing things across them.
- 16:21And climate, you know, which is its own fund.
- 16:23That's important to us. And one thing we feel strongly
- 16:26about as a firm, which is a little bit different from other
- 16:29platforms is that each of us. Should make investments and have
- 16:33insight into each of these categories.
- 16:35We don't want someone to be on fintech and someone to be on
- 16:37education because our firm is really small, right?
- 16:40There's only, you know, a small handful of partners and we want
- 16:45a lot of shared knowledge and conversation and debate.
- 16:49So we don't want a situation where something comes in and we
- 16:51say this is a climate investment.
- 16:53So like Albert, you know, what do you think about that?
- 16:55Or it's the Fintech investment, John, like what should we do?
- 16:57We want it to be everyone's. Responsibility to have an
- 17:01insight and have our perspective and I think that's done by us
- 17:04all investing across each of the buckets.
- 17:07You said right before we got into this, you thought consumer
- 17:09was about to take off. Why?
- 17:12Why do you think that? The piece of the A I craziness
- 17:16that I'm most excited about is the application layer.
- 17:19I think there's still a lot of kind of complexity and
- 17:22uncertainty on the foundational model and on the enabling
- 17:27infrastructure on where equity value aggregates, right, how
- 17:30much of the stack the models own, how defensible those models
- 17:34are. You know how that shakes out.
- 17:36But what I feel like we can have more conviction about is that it
- 17:40unleashes. A wave of consumer innovation
- 17:43that's going to be really fun because the way this is going to
- 17:46get utilized is by products that we want to use.
- 17:50I'm excited about unleashing this rejuvenated value around
- 17:54fun things to do right where the coolest thing about AI driven
- 17:59applications is. They get better if people
- 18:02actually use them. So the strongest incentive of
- 18:05the team is to increase engagement in utility.
- 18:08And I think the only way to do that is to combine utility with
- 18:11fun. There's going to be so many
- 18:13things in the market that if things aren't fun to use, you'll
- 18:15go to another option. But the team has a huge
- 18:18incentive to get you to stick because that's how their product
- 18:21gets better. So if you think about something
- 18:22like Duolingo which is you know been on this for a long time of
- 18:26leveraging machine learning and I I to create.
- 18:29Better, you know, consumer experiences, streaks,
- 18:32gamification, fun, infused with the utility of language learning
- 18:37is critical because their product gets better if I use it.
- 18:39And I'm really excited to see that apply to lots of different
- 18:43consumer applications. And I think we've been talking a
- 18:46lot and everyone's been talking a lot about where they're going
- 18:48to be moats, right? You know, is stickiness going to
- 18:51be possible? The barriers feel low.
- 18:54And I think the Moat is going to be fun and teams that can create
- 18:58rapid new fun things that keep you on the platform.
- 19:02And we haven't seen that in a while and I'm excited about it.
- 19:05Chat bots I guess would be sort of front of mind in terms of
- 19:09consumer, you know you have companies like character.
- 19:13Is that the kind of thing you're thinking about or you're
- 19:15thinking of like more on the other end of the spectrum, like
- 19:18pure games that sort of employ large language models in some
- 19:23way, or any sort of more specificity on the type of thing
- 19:27you're seeing? I don't know that we're even
- 19:29fully seeing it yet. I think we've seen a lot in
- 19:31learning. I think we're going to see a lot
- 19:34in Consumer Financial services, maybe even in healthcare, right.
- 19:38There's a huge advantage to companies that can get me sticky
- 19:42on being a point of entry for care in terms of diagnostics and
- 19:46kind of data networks. But you got to make me want to
- 19:49use it right and. I don't know that we've fully
- 19:51seen these come to life yet. I think chat bots are a start,
- 19:54but I don't think kind of a chat bot interface on its own is
- 19:58going to be fun enough. And what you're seeing in this
- 20:00kind of early 1st wave of consumer applications on these
- 20:04models is high trial, low engagement, right.
- 20:08So you see, you know, big usage numbers out of a gate and top
- 20:13line and then very low. 306090 day engagement because I think
- 20:17we're in a period of trial behavior like me and everyone
- 20:20else will try anything that comes along.
- 20:22It's so easy to try and we're all so curious.
- 20:24But the real indication is what I'm still using, you know, a few
- 20:29months from now. I know, even with ChatGPT.
- 20:32I mean partially. It feels like they're maybe
- 20:34degrading the quality of the service, but I use it regularly
- 20:39for proofreading. Still like it's good at catching
- 20:41random typos, but I don't think. You know, in the beginning I was
- 20:45having like long conversations with him.
- 20:47Really. It was like in a let's feel out
- 20:50sort of how powerful this thing is and sure, really get a sense
- 20:53of it. And the novelty of that winds
- 20:55down, I don't know. Do you find yourself using it
- 20:58much these days? You know, I use it for a very
- 21:02specific use case every day, which is I, you know, I used to
- 21:05use it in the same way, like kind of as a toy or for help
- 21:09writing. I found myself doing that less.
- 21:12What I use it for actually, is that my son, who's 5, loves
- 21:16having it create bedtime stories for him.
- 21:18So he loves the idea of telling it.
- 21:20I want to hear a story about Max, who's his name, and my
- 21:23brother Leo, and we meet Spiderman and we go to a glacier
- 21:28and we fight Green Goblin and he loves being able to play with
- 21:32those inputs and have it tell a story.
- 21:34And I really like it because I used to have to make up those
- 21:36stories every night and now it does it for me.
- 21:39And he thinks, you know, the Chad GBG stories are certainly
- 21:41better than my made-up stories, which is interesting cuz that's
- 21:44a full toy use case. But it's sticky because he
- 21:46thinks it's right, right. And so I'm like that's.
- 21:50A business, you know, there are lots of maybe clearly people
- 21:53will make children's books with this.
- 21:55Or, you know, I mean people used to do all those, like fill in
- 21:57the blank. People love the idea of like,
- 21:59oh, you put your name in it, but you do that like most nights
- 22:02now, basically every night. I mean that I'm home.
- 22:06Oh my God, that's amazing. Are you searching for companies
- 22:11with like AI in mind or would you invest in a company right
- 22:14now? To put it a totally different
- 22:16way, that is not sort of talking about AI like it.
- 22:20Does every company in some ways need to be using language models
- 22:25to be relevant to investors at the moment, or do you still see
- 22:28like? People with like totally
- 22:30different theses that are unrelated that are exciting to
- 22:33you. We absolutely see companies that
- 22:35are exciting. I mean I can think about pieces
- 22:37of climate for example, that are not related to AI.
- 22:40However, I think very similar to mobile.
- 22:43If you're talking to a company and mobile should be a part of
- 22:48their strategy or could add leverage to their strategy, you
- 22:51want them to talk about it, right.
- 22:52It doesn't have to be the first thing you're doing.
- 22:54It doesn't have to be the core of their business, but it's an
- 22:57important component of it. So if you're thinking about
- 23:00education companies right, where you spend a fair amount of time
- 23:03on direct to learner education, A I has been instrumental in
- 23:07lowering the cost of creation in a lot of ways and personalizing
- 23:10learning. It doesn't have to be that their
- 23:12thing is an A I company, but we would be curious if that's a
- 23:16tool set that adds leverage to what they're doing.
- 23:19Healthcare, right. We spend a fair amount of time
- 23:21and access to care. There's a lot going on there
- 23:24about how AI can offer more personalized care and change the
- 23:27cost structure. I would argue that one of the
- 23:30most, if not the most most important thing to do in
- 23:32healthcare right now is to change the cost structure, and
- 23:34that's an important tool. Maybe they've come up with a
- 23:36different way to do it that's, you know, also exciting.
- 23:39So it's not a gating item for us, but it's coming up in a lot
- 23:42of conversations. Yeah.
- 23:45I mean with mobile it's a little more clear like.
- 23:50Are you going to be there like there's this, it's a new way to
- 23:53get users that sort of quickly growing.
- 23:55You're going to be differentiated from your
- 23:57competitors with like, you know the LLMS.
- 24:01It's a little more varied in like whether it's like a tool to
- 24:04make you more productive or it's not always clear to companies
- 24:08like which. Piece of their business, they're
- 24:10supposed to use it for totally, yeah.
- 24:12And I think a big question is, is it customer user facing or is
- 24:16it internal efficiency? I think for a lot of the
- 24:18companies, right, the lowest hanging fruit is going to be
- 24:21internal efficiency. Can you make tasks that you do
- 24:24that add cost internally more efficient leveraging some of
- 24:28these tools and improving your margin structure and that is
- 24:32likely to come into play before it's a, you know, a user or a
- 24:35customer facing tool. Do you see venture capitalists
- 24:38doing that? Do you think like Llms will be
- 24:40useful for what you do? I'm sure it will be in a lot of
- 24:44ways. There are a lot of rote tasks we
- 24:46do, you know, areas that we've been thinking about where it's
- 24:49particularly useful. Obviously, rote tasks is one.
- 24:52Companies have more of them, especially as they scale, than
- 24:56venture capitalists that we've discovered.
- 24:58But I'm sure there are ways. USV is a relatively boutique
- 25:03firm, right? We're not doing so many
- 25:05investments each year. A lot of it is dependent on a
- 25:08small group of people sitting around in a room and really
- 25:10hashing out our thesis and ideas.
- 25:12It's not scale, right? Like it's kind of the antithesis
- 25:15of scale in a lot of ways despite our interest in scaling
- 25:18companies. And so it doesn't feel to me the
- 25:21most natural fit. But we have a lot of data and
- 25:24I'm sure we will, you know, think about using.
- 25:26We're playing with a bunch of different things internally all
- 25:28the time. I don't know that we've like
- 25:29found it's, you know, sweet spot.
- 25:31But the other place we think about its utility is where are
- 25:35there complex interfaces that you use, whether it's SQL or
- 25:40Excel, right, or it's Salesforce where people get hired
- 25:43particularly to interact with an interface.
- 25:46Or, you know, you can take an Excel class, right?
- 25:48But it's all data on the back end.
- 25:50And I think one of the lowest hanging fruits is transforming
- 25:53that interface. And there's applications for our
- 25:55business around that. So no doubt there'll be
- 25:58intersections. I'm not sure we've nailed it
- 26:00right now. It's shifting gears to the
- 26:02Climate Fund. Have you invested out of the
- 26:05Climate Fund in anything that's like truly non tech in some way
- 26:10or it's more just it's tech but it's like super heavy capital
- 26:15intensive hardware. It's more the latter, it's more
- 26:18the latter, right? We did micronuclear reactor
- 26:21investment. Really cool.
- 26:23Micro. Honestly don't know.
- 26:25Oh, the nuclear reactors are small.
- 26:27They're actually in shipping containers.
- 26:29Whereas generally, wow, reactors are really big.
- 26:31Yeah, it's really cool. It's called radiant.
- 26:34Exist or this is like they exist.
- 26:37They can be built and piloted, but it will take a long time for
- 26:40them to be really, you know, rolled out and commercialized.
- 26:43And there's regulatory writ. There's all kinds of risk with
- 26:45it. And we also think that nuclear
- 26:47is an essential piece of the pie and changing the energy
- 26:49spectrum. So both are important.
- 26:51We think in our climate fund really deliberately around fund
- 26:54construction, right. It was important for us to have
- 26:57a nuclear investment in the fund.
- 26:58It's also important for us to not have so many nuclear
- 27:01investments in the fund. And so we think about that
- 27:04balance really particularly, honestly, probably more
- 27:07specifically than we do in the core fund.
- 27:10I mean, small nuclear was very interesting.
- 27:12Are there other ones that are like are fun to hear about at
- 27:14the moment or that you think are particularly interesting in the
- 27:18funds lots? Yeah, the Climate Fund has kind
- 27:20of been fun because you know, I guess actually these days
- 27:24between climate and psychedelics, like I have a lot
- 27:26of party conversation people, but often times I don't.
- 27:30And it's like here's a B to B marketplace I think is really
- 27:33interesting but like you're not going to think, is that it?
- 27:35People love to be like what do you investigate?
- 27:38But the Climate Fund is actually like a gold mine cuz it's a lot
- 27:42of really cool stuff. We have Remora which is doing
- 27:45carbon capture off the back of semi trucks.
- 27:47We've been very interested in how can you take existing.
- 27:50We split the fund into mitigation and adaptation,
- 27:53right. Mitigation is how do you
- 27:56decarbonize the planet, right? How do you prevent more carbon
- 28:00in the atmosphere and sequester carbon?
- 28:02Adaptation is how do we adapt to a world where this is what's
- 28:06going on, right? A world of kind where you're
- 28:09going to have more extreme weather events, where you know
- 28:12we have this changing ecosystem and planet, What do we need to
- 28:15do to live in it? And so we put investments in
- 28:18both in the fund. So for example adaptation we
- 28:21have flood map right which is a data network around predicting
- 28:25floods which is going to be enormous ly important given the
- 28:29weather patterns that we're seeing mitigation we have
- 28:33something like remora which is you know carbon capture off the
- 28:36back of semi trucks. We have an existing, you know,
- 28:39world of semi trucks driving across the country, very hard to
- 28:43stop that, very problematic to the American economy to stop
- 28:46that. But how do you adapt them to be
- 28:48able to, you know, further mitigation of the climate
- 28:52crisis? Well, you can attach these
- 28:55hardware contraptions and capture carbon along the way.
- 28:57So there's a lot of really interesting innovation coming
- 29:02out of it. You know, I always say, you
- 29:04know, if future generations get the ability to look back at
- 29:07ours, they'll be very critical of where we allowed this planet
- 29:12to get to, but amazed at what innovation could do to change
- 29:15course. And they'll only be able to do
- 29:17that if it does change course. And if it doesn't, it'll be mute
- 29:20because they won't be there to tell us.
- 29:22It's easy to fall into this sort of.
- 29:24I feel like the tech mindset can sometimes fall into.
- 29:27Oh, this problem will get solved.
- 29:29You know, it's like there was just that article about the
- 29:31Super white paint that is very reflective.
- 29:34It's like, oh, we can just deploy that.
- 29:36But obviously, you know, somebody has to do the solving,
- 29:39which is also sort of the entrepreneurial sort of tech
- 29:42mindset. It's like, yeah, the money has
- 29:44to be deployed. Like somebody has to go do it.
- 29:47It's not you can't just sort of like, oh, we tend to work things
- 29:50out, you know, I mean that. So yeah, I guess that's the way
- 29:53of say it's good that you guys are doing these climate funds
- 29:55and obviously. Sort of where a firm like USV
- 29:59goes, so goes a lot of Silicon Valley eventually.
- 30:03Are you seeing the growth stage funds?
- 30:06I mean I've written about lower carbon before.
- 30:08Obviously Chris Sacca sort of came out super strong on the
- 30:11early stage. You guys are now sort of coming
- 30:13out strong and there are certainly others, but it doesn't
- 30:16feel like. We've seen sort of the growth
- 30:20stage at the same level or how are you feeling about like
- 30:23follow on capital for the companies you're investing?
- 30:26We've been very focused on this question.
- 30:27First of all, there are some right, you have galvanized which
- 30:31is really interesting. You have some both horizontally
- 30:34interested in climate like a galvanized and then more
- 30:37verticalized around energy or you know different pieces of it
- 30:40that touch it. But overall we think there's a
- 30:43dearth and you see some strategic come in right Benny
- 30:46off. Some people have made huge
- 30:48commitments that they're making good on putting capital at
- 30:51growth stages behind his innovations.
- 30:53But we don't believe there's the systematic growth stage capital
- 30:57that this market needs. And it's not only just later
- 31:01stage venture funds. My partner Albert, what a
- 31:03really, really good blog post on this called the climate funding
- 31:08stack or something like that. You should look it up.
- 31:10But about this issue of building out the financing stack for
- 31:14climate and the reason we think it's important is it's not just
- 31:17raise a big growth fund. Often times these projects have,
- 31:21you know, facilities involved. They may need different forms of
- 31:24financing. You have to combine, you know,
- 31:26an equity financing with different types of debt because
- 31:28they're building, get something out.
- 31:30It's not as simple as scaling software, but it's really
- 31:33important to do. And so we think there's a big
- 31:36opportunity for new funds to form with mixes of capital
- 31:40structures that can support this ecosystem.
- 31:42And we're been very active in talking to people and helping
- 31:46them who are thinking about coming out and doing.
- 31:49That part of the beauty of investing in software is like.
- 31:52You know, if you do it long enough, you can.
- 31:54I mean, I don't do it, but my sense is that you start to see
- 31:58the milestones, that it's like this company, if we invest, if
- 32:01you hit these milestones, you'll probably raise more money.
- 32:04Or at least that was true, maybe less true this year.
- 32:07But like how do you do that with climate companies where first of
- 32:11all, they're much more different one to another?
- 32:12It's not like okay, here's a SAS for X.
- 32:15It's like here's a totally different company.
- 32:17How do you figure out what milestones this company could
- 32:20reach? Before to to get another round
- 32:23of funding, it's a really good question and we spend a lot of
- 32:26time on that internally at the early stages because I totally
- 32:29agree with you. It's much more complex and
- 32:32varied than you know. There's a there's limitless
- 32:35blogs out there on you know milestones for SAS companies on
- 32:38raising different rounds and this is not it And in some ways
- 32:42the most complicated part is the market doesn't really know yet,
- 32:46right. There isn't I don't think a
- 32:47horizontal answer. And there's a lot that goes into
- 32:50the climate fund, right? There's software companies,
- 32:52carbon chain, which is carbon accounting for source of truth
- 32:55for supply chains. That looks a lot like a SAS
- 32:58company, right? The milestones involved are
- 33:00going to be a lot like a SAS company.
- 33:02It's going to be underwritten that way, you know.
- 33:04But then there's you know the nuclear come radiant totally
- 33:09different in milestones you can't do it off of revenue.
- 33:12And so we do a lot of talking to the market, right, like before
- 33:15we go into categories really doing our homework on what those
- 33:19downstream investors would want to see.
- 33:21What you know the expectation is to unlock different levels of
- 33:24capital, how much capital is going to be necessary to get
- 33:28these companies to the proof points and trying to underwrite
- 33:30that. And as we all know, sometimes
- 33:32that's not so clear at the early days.
- 33:35We also we tailor the capital we put in to the different rounds
- 33:39to that capital risk. We think about that a lot more
- 33:42in the Climate fund in many ways than we do in the core fund,
- 33:45because that ecosystem is evolving.
- 33:47As in not just deploying a ton of money to something because it
- 33:51will need it or what do you mean you tailor the capital, meaning
- 33:55if we think that risk is higher, we may do a smaller seed, right?
- 33:59We tailor our own exposure depending on the risks.
- 34:02Involved. You do the stage.
- 34:03You're like, oh, we'll do a seat.
- 34:05Yeah, that makes sense. I said at the beginning of this
- 34:08that I would ask you about your career and sort of looking at it
- 34:12in this down market. I mean, you know, it feels to me
- 34:17like, you know, there was a period where it seemed like
- 34:19every promising up and coming VC and certainly I put you in that
- 34:25category. I was like oh, should I be
- 34:27starting a fund? Like did you consider starting a
- 34:30fund when you went to USV and LIKE?
- 34:33That for a while that seemed great, like you're going to get
- 34:36a lot of the economics and like there's potentially more upside.
- 34:40But then now, you know, I feel like many of those same funds
- 34:44are the ones where LP's are sort of much more cautious and might
- 34:48be the hardest to raise anyway. So that's me laying out.
- 34:52What I see is sort of how things went.
- 34:54But I'm curious, yeah, for you just like how you thought about
- 34:58the decision to go to sort of an established firm versus maybe?
- 35:02Setting out on your own, Yeah, I mean, a couple of things.
- 35:06One, I actually think some of the new franchises and platforms
- 35:10that are coming out are extremely exciting.
- 35:12You know, I look at what friends of mine are building in all
- 35:15kinds of different realms, whether that's like a Pace
- 35:17Capital or what, you know, Justin April are building or 12
- 35:21Below in New York or these kind of different platforms.
- 35:25And you look at them and there's so much hustle, there's so much
- 35:28perspective. The networks are so strong,
- 35:30there's a lot to prove. But one thing I love about
- 35:33venture is it really favors the hungry.
- 35:35You know, you're only as good as the fund you're deploying right
- 35:38now. All of those past successes can
- 35:41make old partners rich, but they can't make you, you know, win
- 35:44that next deal if you don't get out there and hustle for it and
- 35:48you can be outworked and out hustled.
- 35:50And I, you know, there are a lot of people doing it.
- 35:52And so there is a natural evolution of platforms and Lps I
- 35:57think are excited about them. So I actually think it's a
- 35:59pretty interesting time. That being said.
- 36:02Sorry to interrupt. Well, I'll let you keep going
- 36:03with this point, but I mean Pittsburgh put out data that
- 36:06affirmed that there is, it seems like Lps are favoring existing
- 36:11firms. I mean, of course Lps are
- 36:13favoring. That doesn't mean the sort of
- 36:14the coolest new, right? Right.
- 36:16Yeah, okay. As long as we're aligned on that
- 36:18sort of being the universe, right, the data is the data
- 36:20right. Like of course Lps are favoring
- 36:22existing firms, right? And especially in times of come
- 36:25all you pull to the kind of, you know, most obvious ones.
- 36:29But there's also a lot of data that in many cases first funds
- 36:32outperform, right. That like many platforms are
- 36:36never as good as the first fund. I am, you know, banking my
- 36:39career that USB will outperform USB's first fund, which is hard
- 36:43to do because that was an epic first fund.
- 36:46But I'm going to, you know, work my ass off until we do that.
- 36:50But you know, there's a reason why and I think it has to do
- 36:54with risk tolerance and hunger and it's a really cool element,
- 36:56I think, of the venture ecosystem that's very much in
- 36:58play right now. That being said, you know I
- 37:03think everyone has their own set of aspirations and mine is to be
- 37:08you know, one of the, you know, best investors of my generation
- 37:12in terms of returns and firm building and working with and
- 37:18behind companies that I can be proud to be a part of.
- 37:22And that is kind of I've always been very clear on that being my
- 37:25aspiration. It wasn't to start my own thing.
- 37:28And so if I felt like I could accomplish those goals on a
- 37:31platform I was excited about, you know that was what I wanted
- 37:35to do. And and I think USB is really
- 37:37unique everything from the way we're structured and set up to
- 37:40how our partnership works. And I frankly don't think I
- 37:43could. You know, I know I couldn't
- 37:45recruit a set of more impressive partners if I went out and
- 37:48tried. And, you know, I couldn't think
- 37:51of a reason why that would have been a better choice for me.
- 37:53What's your sense of how screwed like the venture capital asset
- 37:57classes right now overall? I mean you know with I feel like
- 38:03with interest rates going up, there's been more and more
- 38:05concerned that just like the sort of median venture
- 38:11performance isn't like good enough to justify.
- 38:14Sort of the investments in a world where Lps can go
- 38:19elsewhere, I mean obviously USV sort of is fine, but I'm just
- 38:23curious like how venture broadly does affects you because it
- 38:27affects you know, the financing, everything like that.
- 38:30So yeah, what's your read of the market?
- 38:32Probably most importantly, it affects the appeal of great
- 38:35founders to start companies, right?
- 38:38Like people start companies when they feel like funding is there
- 38:42and they're excited about platform shifts and
- 38:43opportunities. And so it matters a lot I think
- 38:47of the broad perception for the talent, which is I would argue
- 38:50in many ways the most important piece of it.
- 38:52I think it's a mixed story. I think the vintages of the last
- 38:57few years are going to be very tough for every obvious reason,
- 39:01right. The entry prices, the reset of a
- 39:04market, the potential outcomes, the crowdedness, all of it is
- 39:09going to make a set of vintages very tough to prove out and are
- 39:14going to be a little bit of a bloodbath to watch.
- 39:17But venture is cyclical and at heart is about you know putting
- 39:22early capital into powerful new technologies particularly around
- 39:26shifting markets, right, the market creation and we're
- 39:30straight in the middle of that, right.
- 39:31We are seeing that happen. It's an essential time for that
- 39:34to happen and in some of the most exciting ways.
- 39:38Categories that we've long-awaited to intersect with
- 39:41technology shifts I think are happening right Healthcare and
- 39:44education and financial services.
- 39:46I feel like those intersections are coming to fruition in a more
- 39:50concrete way through some of these technologies that we're
- 39:53seeing and products being built then has happened before.
- 39:57And that's extremely exciting and we're seeing a dramatic
- 40:00talent shift to it. More people want to go out and
- 40:02start climate businesses. They want to work on things that
- 40:05matter. It's less appealing to stay at
- 40:07large platforms that are, you know, bumpy or late stage
- 40:11companies where they don't know that you know their options are
- 40:13above water and so they're going out and they're starting
- 40:16businesses. So there's a lot of recipes for
- 40:19the next. Set of years to be a very good
- 40:22time in venture interest rates and chaos and all, but have we
- 40:29all learned to be pretty cautious on entry prices?
- 40:32Have we learned to slow down? I think hopefully these lessons
- 40:36at least have some longevity, even though I know memories are
- 40:39short. With large language models and
- 40:42AI totally believe it and get it, it's like, OK, this is sort
- 40:47of a transformational technology like.
- 40:49We're in a downturn, but who cares?
- 40:51It's like if mobile came around, you know, when the world was
- 40:54ending, like a great VC firm should have tried to gobble
- 40:57everything up that they could. And I mean some of.
- 41:00Yeah, anyway, so, so I get that. And with climate to some degree,
- 41:05there's more capital and interest and excitement and
- 41:07belief sort of happening. I don't quite get on sort of the
- 41:12healthcare education side. What like the technological
- 41:17inflection point? Is at the moment or like because
- 41:22I mean the regulatory problems have stayed the same.
- 41:25I think some of the regulatory problems might shift.
- 41:27But on the technology piece of it, I would argue the biggest
- 41:32problem in those systems is a cost issue, right.
- 41:35They're kind of purposefully exclusionary.
- 41:37They are complicated. They are one-size-fits-all and
- 41:41they are too expensive. It's actually the healthcare and
- 41:44education have very different problems from each other in lots
- 41:47of ways. But I think have that set of
- 41:49issues in common. And the best way to change that
- 41:54is technology, because in many ways that's a product problem.
- 41:57And scalable technology that can personalize delivery of care,
- 42:03delivery of education, can change a cost curve and create
- 42:06new forms of access. And I think we are seeing some
- 42:09of that technology be built and products come to life in a much
- 42:16more accelerated way right now than we have before and in ways
- 42:19that we're gonna finally break through some of that noise.
- 42:22Our strong belief is that to your point on regulation is that
- 42:25these systems are gonna change from the outside in that
- 42:28fighting from internally in the structure and selling into them
- 42:31is a slog and is incremental change.
- 42:33But enough pressure from users, being able to use new products
- 42:37and services at the right cross structure from the outside can
- 42:40put pressure on and change structures outside in And I
- 42:43think we are going to start to see that in important.
- 42:47Great. Rebecca, thank you so much for
- 42:49coming on the show. I really appreciate it.
- 42:51Thank you for having me. That's the episode.
- 42:53I'm Eric Newcomer. Thanks so much, Rebecca Cayden.
- 42:55Shout out to Tommy Herron, our audio editor, Riley Consello.
- 42:58My chief of staff, Annie Wen, our intern, is helping with
- 43:02producing young Chomsky for the wonderful theme music.
- 43:05Please like comments, subscribe on YouTube, give us a review on
- 43:09Apple Podcasts, and subscribe to the Stop Stack newcomer.co.
- 43:13Thanks so much. Goodbye.
- 43:14Goodbye. Goodbye.
- 43:16Goodbye. Goodbye.
- 43:16Goodbye. Goodbye.
- 43:17Goodbye. Goodbye.
- 43:18Goodbye.